BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Third Quarter Earnings Webcast

  July 23, 2009

   · 

  1 min read
• Drug Development

  AlphaRx Inc. Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting

  July 23, 2009

   · 

  1 min read
• Business

  Isis Pharmaceuticals, Inc. Second Quarter 2009 Financial Results Conference Call

  July 23, 2009

   · 

  1 min read
• Drug Development

  Access Pharmaceuticals Release: MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients

  July 23, 2009

   · 

  1 min read
• Business

  Alexion Pharmaceuticals Inc. Q2 Profit Beats Street, Raises FY 2009 Outlook

  July 23, 2009

   · 

  1 min read
• Business

  Massachusetts Institute of Technology (MIT) Granted an 8,000 Square Foot Operation Facility in Taizhou City for a Period of 2 and Half Years

  July 23, 2009

   · 

  1 min read
• Business

  MonoSolRx LLC Appoints Theodore Clemente Vice President Business Development

  July 23, 2009

   · 

  1 min read
• Job Trends

  Eli Lilly and Company and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs; ImClone Systems Incorporated to Locate Resea

  July 23, 2009

   · 

  1 min read
• Drug Development

  Arno Therapeutics Announces Enrollment of First Patient in Phase II Study of AR-67 (formerly DB-67) in Patients with Myelodysplastic Syndrome

  July 23, 2009

   · 

  1 min read
• FDA

  Allergan Inc. (JOBS) Receives FDA Approval for ACUVAIL Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery

  July 23, 2009

   · 

  8 min read